Have a question?
Please get in touch with our team in case of any queries
THE LIVE CELL IMAGING MARKET SIZE WAS VALUED AT USD 2.18 BILLION IN 2021 AND IS EXPECTED TO REACH USD 3.54 BILLION BY 2027, GROWING AT A CAGR OF 8.44%.
Live Cell Imaging Market Research Report Includes Size, Share, & Trends Analysis By
- Product: Equipment, Consumables, and Software
- Technique: Fluorescence microscopy, Confocal microscopy, Transmitted light microscopy, and Others
- Application: Cell Biology, Drug Discovery, Developmental Biology, and Stem Cells
- End-user: Pharma & Biotech Companies, Academic & research centers, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
LIVE CELL IMAGING MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2027) | USD 3.54 Billion |
| Market Size (2021) | USD 2.18 Billion |
| CAGR (2022-2028) | 8.44% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Product Type, Technique Type, Application Type, End-User Type |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
The global live cell imaging market was valued at USD 2.18 billion in 2021 and is expected to reach USD 3.54 billion by 2027, growing at a CAGR of 8.44% from 2022 to 2027. Live cell imaging is one of the popular techniques for studying live cells and investigating the biological processes in real-time. It utilizes time-lapse microscopy and careful preparation of living cell environments that have made it easier to observe cell-to-cell interactions and study the behavior of single cells and related changes within the cell. In 2021, North America accounted for the highest share of the global live cell imaging market.
Live cell imaging has revolutionized studying cells, processes, and molecular interactions. Imaging techniques for living cells allow scientists to study cell structures and processes in real-time and over time. Such factors have significantly impacted the growth of the market. A few of the most widespread applications include examining the structural components of a cell, the dynamic studying processes, and the localization of molecules.
MARKET TRENDS & DRIVERS
Rising Target Patient Population
Live cell imaging is a vital tool in the study of cancer biology. Although high-resolution imaging is indispensable for studying genetic and cell signaling changes in underlying cancer, live cell imaging is essential for a deeper understanding of the function and disease mechanisms. Around 400,000 children develop cancer every year. Developed and emerging countries are facing the burden of communicable diseases. Most developing countries get exposed due to several factors that include demographic, socio-economic, and geographic conditions. Hence, the growing number of deaths and chronic conditions drive the live cell imaging market.
Deep Learning & Artificial Intelligence
The role of Artificial intelligence (AI) in life science is rapidly expanding and holds great potential for microscopy. In the past, the power of microscopy for supporting or disproving scientific hypotheses got limited by scale, and the time associated with quantifying, capturing, and analyzing large numbers of images was often prohibitive. Recently, AI has made fast inroads into many scientific fields and the world of microscopy. AI-based self-learning microscopy shows the potential to produce high throughput image analysis that is more effortless and less time-consuming. Newer AI technology allows better visualization of unlabeled live cells over a prolonged period.
Increase in Funding for Cell & Gene Therapy
The demand for regenerative medicine has increased across developed countries, and investments in cell & gene therapy have grown drastically in recent years. The public and private sectors are at the forefront of funding cell and gene therapy developers. Recently, many government organizations and private firms have started funding many biotech start-ups and research institutes that invest in the R&D of cell and gene therapy products. According to the Alliance for Regenerative Medicines, there was a 164% jump in funding for cell & gene therapy in 2019 compared to 2017.
Advancements & Newer Imaging Techniques
Live cell imaging arises from scientific interest coupled with imaging and labeling technology improvements. Putting together various technological advancements with biological interests gives scientists many more ways to use live cell imaging. In particular, exciting progress in probe development has enabled a broad array of nucleic acids, proteins, glycans, lipids, ions, metabolites, and other targets to be labeled. Many recent advancements in microscopic technologies use software that enables a better quantitative image analysis of label-free images.
Also, current microscopy techniques limit the quantity and quality of information available to researchers and clinicians and harm the living cells during long-term studies. Hence new imaging technologies are being developed to overcome various limitations. These advancements will help towards future market growth. For instance, the progress of combining 3D fluorescence imaging and holotomography microscopy has overcome some limitations.
Growing Research-based Activities
In the past two decades, the spending on R&D and the introduction of newer drugs have increased rapidly. In 2019, the pharma industry spent around $83 billion on R&D. From 2010 to 2019, the number of novel drugs were approved, whose sales increased by 60% compared with the previous decade, with a peak of 59 new drugs approved in 2018. The rising amount of R&D expenditure and the number of R&D activities in the pharmaceutical sector has led to the significant growth of the market.
SEGMENTATION ANALYSIS
- The global live cell imaging market by product includes sub-segments by equipment, consumables, and software. In 2021, the equipment sector accounted for the highest share in the global live cell imaging market.
Under the equipment sector, live-cell imaging microscopes are opening novel and exciting avenues for studying cellular health, viability, colony formation, migration, and cellular responses to external stimuli. The demand for microscopes is at a larger scale, majorly due to the technological advancements in microscopes and increasing studies into cell behavior. - Fluorescence microscopy, confocal microscopy, transmitted light microscopy, and other techniques are included in the global live cell imaging market by technique. Fluorescence microscopy held the largest share of 53.68% in the global live cell imaging market in 2021. Live-cell imaging techniques are involved in a wide spectrum of imaging modalities, including widefield fluorescence, confocal, multiphoton, total internal reflection, FRET, lifetime imaging, super-resolution, and transmitted light microscopy.
- An increasing number of investigations are using live-cell imaging techniques. Owing to these advances, live-cell imaging has become a requisite analytical tool in most cell biology laboratories. Cell biology, drug discovery, developmental biology, and stem cell are the application's primary segments of the live cell imaging market. In 2021, cell biology accounted for the highest share of 38.72% in the global live cell imaging market.
- The end-user market includes segments by pharma & biotech companies, academic & research institutes, and others. Academic and research institutions identify promising discoveries and seek to initiate their development and commercialization. Most new insights into biology, disease, and new technologies arise in academia, funded by public grants, foundations, and institutional funds. The discovery and development of new therapies have and will likely continue to require contributions from academic institutions and the biopharmaceutical industry.
GEOGRAPHIC ANALYSIS
By geography, the report includes North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2021, North America accounted for the highest share of the global live cell imaging market.
Live cell imaging systems are used for diagnostics purposes, drug discovery & development, and precision medicine. The increase in healthcare expenditures and funding for R&D activities for live cells-driven drug discovery, development, and personalized medicine is one of the major driving factors for leading the North American region. Europe holds the second-largest share of the global market, owing to a growing patient population in need of new treatments such as stem cell therapy and gene therapy, an increasing number of drug approvals for precision medicine, government funding for research-based activities, rapid advancements in live cell imaging, and a variety of other factors.
The APAC region will likely witness the fastest growth in the global live cell imaging market. The significant factors behind this growth can be due to the constant rise in cancers and infectious diseases, growing demand for stem cell research studies, rising R&D expenditures, the increased utility of biomarkers for diagnostic purposes, rising awareness for cell & gene therapies, need for precision medicine, and advances in drug discovery & cell and biology development. However, Latin America and Middle East & Africa accounted for minimal shares in the global market.
COMPETITIVE LANDSCAPE
The leading players in the market are implementing various strategies such as marketing and promotional activities, mergers & acquisitions, product launches, and approvals. Also, high R&D investments and boosting distribution networks have helped companies enhance their market share and presence.
The global live cell imaging market includes global and regional players. Major players contributing to the market's significant shares include Agilent, Bruker, Carl Zeiss AG, Danaher, Merck KGaA, PerkinElmer, and Thermo Fisher Scientific. Other prominent players in the market include Axion (CytoSMART Technologies), Bio-Rad Laboratories, blue-ray biotech, Etaluma, Grace Bio Labs, ibidi GmbH, KEYENCE, NanoEnTek, Nanolive SA, Nikon, Olympus, and others.
Recent Developments in the Global Market
- In 2021, CytoSMART launched CytoSMART Lux3 BR, a new type of bright-field microscope, i.e., a live-cell imaging microscope equipped with a high-quality CMOS camera to assist label-free cell imaging procedures.
- In 2021, the Zeiss group announced that they would launch Zeiss Visioner 1, a Zeiss live cell imaging system, an innovative digital microscope that facilitates real-time all-in-one focus via a micro-mirror array system.
- In 2020, CytoSMART Technologies launched CytoSMART Multi Lux, a remote live cell imaging system.
SNAPSHOT
The live cell imaging market size was valued at USD 2.18 billion in 2021 and is expected to reach USD 3.54 billion by 2027, growing at a CAGR of 8.44% during the forecast period
The following factors are likely to contribute to the growth of the live cell imaging market:
- Rising Number of Patients with Cancers & Infectious Diseases
- Adoption Of High Content Screening Techniques in Drug Discovery & Precision Medicine
- Newer Imaging Techniques Enhancing the Imaging of Live Cells
- Growing R&D Activities in The Pharmaceutical Industry
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the live cell imaging market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report covers both the demand and supply sides of the market. It profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
- Danaher
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- Agilent Technologies
- PerkinElmer
- Merck KGaA
- ZEISS
- Thermo Fisher Scientific
Other Prominent Vendors
- Axion BioSystems
- Business Overview
- Product Offerings
- BD
- Bio-Rad Laboratories
- Blue-Ray Biotech
- Bruker
- Eppendorf
- Etaluma
- Grace Bio-Labs
- ibidi GmbH
- Intelligent Imaging Innovations
- KEYENCE
- Logos Biosystems
- NanoEntek
- Nanolive SA
- Nikon
- Evident
- ONI
- Oxford Instruments
- Phase Focus
- Phase Holographic Imaging PHI AB
- Proteintech Group
- Sartorius AG
- Sony Biotechnology
- Tomocube
Segmentation by Product Type
- Equipment
- Consumables
- Software
Segmentation by Technique
- Fluorescence microscopy
- Confocal microscopy
- Transmitted light microscopy
- Others
Segmentation by Application
- Cell Biology
- Drug Discovery
- Developmental Biology
- Stem Cells
Segmentation by End-Users
- Pharma & Biotech Companies
- Academic & research centers
- Others
Segmentation by Geography
- North America
- THE US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- APAC
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE
Frequently Asked Questions
What is the expected live cell imaging market size by 2027?
What is the live cell imaging market growth?
What are the latest trends in the live cell imaging market?
Who are the market leaders in the global live cell imaging market?
Which region has the largest live cell imaging market share?
EXHIBIT 1 SEGMENTATION OF GLOBAL LIVE-CELL IMAGING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 LIVE-CELL IMAGING PROCESS
EXHIBIT 4 IMPACT OF DEEP LEARNING & ARTIFICIAL INTELLIGENCE ENHANCE LIVE-CELL IMAGING TECHNIQUES
EXHIBIT 5 IMPACT OF INCREASED INVESTMENTS IN CELL & GENE THERAPY PRODUCTS
EXHIBIT 6 GLOBAL FUNDING FOR CELL & GENE THERAPY PRODUCTS 2017–2019 ($ BILLION)
EXHIBIT 7 COMPANIES INVOLVED IN REGENERATIVE MEDICINE R&D ACTIVITIES 2017 & 2018
EXHIBIT 8 IMPACT OF TRACKING SOLUTIONS FOR LIVE-CELL IMAGING
EXHIBIT 9 IMPACT OF ADVANCES IN LIVE-CELL IMAGING
EXHIBIT 10 IMPACT OF RISE IN NUMBER OF PATIENTS WITH CANCERS & INFECTIOUS DISEASES
EXHIBIT 11 IMPACT OF ADOPTION OF HCS METHODS
EXHIBIT 12 IMPACT OF NEW TECHNIQUES IN LIVE-CELL IMAGING
EXHIBIT 13 IMPACT OF GROWTH IN R&D ACTIVITIES IN PHARMACEUTICAL INDUSTRY
EXHIBIT 14 IMPACT OF HIGH COST OF LIVE-CELL IMAGING SYSTEMS
EXHIBIT 15 IMPACT OF CELL VIABILITY & CELLULAR ENVIRONMENT MAINTENANCE CHALLENGES
EXHIBIT 16 IMPACT OF PHOTOTOXICITY & PHOTOBLEACHING IN FLUORESCENCE MICROSCOPY
EXHIBIT 17 GLOBAL LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 18 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT
EXHIBIT 19 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE
EXHIBIT 20 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION
EXHIBIT 21 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER
EXHIBIT 22 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY
EXHIBIT 23 FIVE FORCES ANALYSIS 2021
EXHIBIT 24 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 25 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT
EXHIBIT 26 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 27 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 28 GLOBAL LIVE-CELL IMAGING EQUIPMENT MARKET: INCREMENTAL & ABSOLUTE GROWTH COMPARISON
EXHIBIT 29 GLOBAL LIVE-CELL IMAGING EQUIPMENT MARKET 2021–2027 ($ MILLION)
EXHIBIT 30 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 31 GLOBAL LIVE-CELL IMAGING CONSUMABLES MARKET: INCREMENTAL & ABSOLUTE GROWTH COMPARISON
EXHIBIT 32 GLOBAL LIVE-CELL IMAGING CONSUMABLES MARKET 2021–2027 ($ MILLION)
EXHIBIT 33 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 34 GLOBAL LIVE-CELL IMAGING SOFTWARE MARKET: INCREMENTAL & ABSOLUTE GROWTH COMPARISON
EXHIBIT 35 GLOBAL LIVE-CELL IMAGING SOFTWARE MARKET 2021–2027 ($ MILLION)
EXHIBIT 36 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 37 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
EXHIBIT 38 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE
EXHIBIT 39 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE: INCREMENTAL GROWTH
EXHIBIT 40 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE: ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL LIVE-CELL IMAGING MARKET BY FLUORESCENCE MICROSCOPY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL LIVE-CELL IMAGING MARKET BY FLUORESCENCE MICROSCOPY 2021–2027 ($ MILLION)
EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 44 GLOBAL LIVE-CELL IMAGING MARKET BY CONFOCAL MICROSCOPY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL LIVE-CELL IMAGING BY CONFOCAL MICROSCOPY MARKET 2021–2027 ($ MILLION)
EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 47 GLOBAL LIVE-CELL IMAGING MARKET BY TRANSMITTED LIGHT MICROSCOPY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL LIVE-CELL IMAGING MARKET BY TRANSMITTED LIGHT MICROSCOPY 2021–2027 ($ MILLION)
EXHIBIT 49 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 50 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021–2027 ($ MILLION)
EXHIBIT 52 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 53 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 54 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION
EXHIBIT 55 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 56 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL LIVE-CELL IMAGING MARKET BY CELL BIOLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL LIVE-CELL IMAGING MARKET BY CELL BIOLOGY 2021–2027 ($ MILLION)
EXHIBIT 59 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 60 GLOBAL LIVE-CELL IMAGING MARKET BY DRUG DISCOVERY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL LIVE-CELL IMAGING MARKET BY DRUG DISCOVERY 2021–2027 ($ MILLION)
EXHIBIT 62 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 63 GLOBAL LIVE-CELL IMAGING MARKET BY DEVELOPMENTAL BIOLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL LIVE-CELL IMAGING MARKET BY DEVELOPMENTAL BIOLOGY 2021–2027 ($ MILLION)
EXHIBIT 65 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 66 GLOBAL LIVE-CELL IMAGING MARKET BY STEM CELL RESEARCH: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 67 GLOBAL LIVE-CELL IMAGING MARKET BY STEM CELL RESEARCH 2021–2027 ($ MILLION)
EXHIBIT 68 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 69 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 70 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER
EXHIBIT 71 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 72 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 73 GLOBAL LIVE-CELL IMAGING MARKET BY PHARMA & BIOTECH COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 74 GLOBAL LIVE-CELL IMAGING MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 ($ MILLION)
EXHIBIT 75 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 76 GLOBAL LIVE-CELL IMAGING MARKET BY ACADEMIC & RESEARCH INSTITUTES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 GLOBAL LIVE-CELL IMAGING MARKET BY ACADEMIC & RESEARCH INSTITUTES 2021–2027 ($ MILLION)
EXHIBIT 78 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 79 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 80 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021–2027 ($ MILLION)
EXHIBIT 81 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 82 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 83 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY
EXHIBIT 84 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY: KEY COUNTRIES (2021) ($ MILLION)
EXHIBIT 85 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 86 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 87 NORTH AMERICA LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
EXHIBIT 88 NORTH AMERICA LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 89 NORTH AMERICA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 90 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 91 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
EXHIBIT 92 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 93 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 94 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 95 US LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 96 CANADA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 97 EUROPE LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
EXHIBIT 98 EUROPE LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 99 EUROPE LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 100 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 101 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
EXHIBIT 102 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 103 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 104 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 105 GERMANY LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 106 FRANCE LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 107 UK LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 108 ITALY LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 109 SPAIN LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 110 APAC LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
EXHIBIT 111 APAC LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 112 APAC LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 113 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 114 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
EXHIBIT 115 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 116 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 117 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 118 CHINA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 119 JAPAN LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 120 INDIA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 121 SOUTH KOREA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 122 AUSTRALIA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 123 LATIN AMERICA LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
EXHIBIT 124 LATIN AMERICA LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 125 LATIN AMERICA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 126 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 127 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
EXHIBIT 128 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 129 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 130 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 131 BRAZIL LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 132 MEXICO LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 133 ARGENTINA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 134 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET: KEY COUNTRIES (2021)
EXHIBIT 135 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 136 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 137 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
EXHIBIT 138 INCREMENTAL GROWTH BY TECHNIQUE 2021 & 2027
EXHIBIT 139 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 140 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 141 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 142 TURKEY LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 143 SAUDI ARABIA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 144 SOUTH AFRICA LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 145 UAE LIVE-CELL IMAGING MARKET 2021–2027 ($ MILLION)
EXHIBIT 146 PURE AND DIVERSIFIED PLAYERS IN THE GLOBAL LIVE-CELL IMAGING MARKET
EXHIBIT 147 GLOBAL LIVE-CELL IMAGING MARKET: KEY VENDORS STRENGTHS & CAPABILITY ANALYSIS
EXHIBIT 148 MARKET POSITION OF MAJOR PLAYERS IN THE GLOBAL LIVE-CELL IMAGING MARKET
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 COMMON BIOLOGICAL APPLICATIONS OF LIVE-CELL MICROSCOPY PROCEDURES
TABLE 4 TYPICAL DURATION OF COMMONLY PERFORMED APPLICATIONS WITH LIVING CELLS
TABLE 5 PARAMETERS TO MAINTAIN CELL HEALTH DURING LIVE IMAGING
TABLE 6 VARIOUS COMPANIES THAT OFFER CONSUMABLES & ACCESSORIES FOR LIVE-CELL IMAGING
TABLE 7 VARIOUS COMPANIES AND THEIR SOFTWARE FOR LIVE-CELL IMAGING
TABLE 8 DANAHER: MAJOR PRODUCT OFFERINGS
TABLE 9 AGILENT TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 10 PERKINELMER: MAJOR PRODUCT OFFERINGS
TABLE 11 MERCK KGAA: MAJOR PRODUCT OFFERINGS
TABLE 12 ZEISS: MAJOR PRODUCT OFFERINGS
TABLE 13 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 14 AXION BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 15 BD: MAJOR PRODUCT OFFERINGS
TABLE 16 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 17 BLUE-RAY BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 18 BRUKER: MAJOR PRODUCT OFFERINGS
TABLE 19 EPPENDORF: MAJOR PRODUCT OFFERINGS
TABLE 20 ETALUMA: MAJOR PRODUCT OFFERINGS
TABLE 21 GRACE BIO-LABS: MAJOR PRODUCT OFFERINGS
TABLE 22 IBIDI GMBH: MAJOR PRODUCT OFFERINGS
TABLE 23 INTELLIGENT IMAGING INNOVATIONS: MAJOR PRODUCT OFFERINGS
TABLE 24 KEYENCE CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 25 LOGOS BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 26 NANOENTEK: MAJOR PRODUCT OFFERINGS
TABLE 27 NANOLIVE SA: MAJOR PRODUCT OFFERINGS
TABLE 28 NIKON: MAJOR PRODUCT OFFERINGS
TABLE 29 EVIDENT: MAJOR PRODUCT OFFERINGS
TABLE 30 ONI: MAJOR PRODUCT OFFERINGS
TABLE 31 OXFORD INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 32 PHASE FOCUS: MAJOR PRODUCT OFFERINGS
TABLE 33 PHASE HOLOGRAPHIC IMAGING PHI AB: MAJOR PRODUCT OFFERINGS
TABLE 34 PROTEINTECH GROUP: MAJOR PRODUCT OFFERINGS
TABLE 35 SARTORIUS AG: MAJOR PRODUCT OFFERINGS
TABLE 36 SONY BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 37 TOMOCUBE: MAJOR PRODUCT OFFERINGS
TABLE 38 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 39 GLOBAL LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 (%)
TABLE 40 NORTH AMERICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 41 NORTH AMERICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 (%)
TABLE 42 EUROPE LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 43 EUROPE LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 (%)
TABLE 44 APAC LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 45 APAC LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 (%)
TABLE 46 LATIN AMERICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 47 LATIN AMERICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 (%)
TABLE 48 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 ($ MILLION)
TABLE 49 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY PRODUCT 2021–2027 (%)
TABLE 50 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 ($ MILLION)
TABLE 51 GLOBAL LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 (%)
TABLE 52 NORTH AMERICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 ($ MILLION)
TABLE 53 NORTH AMERICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 (%)
TABLE 54 EUROPE LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 ($ MILLION)
TABLE 55 EUROPE LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 (%)
TABLE 56 APAC LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 ($ MILLION)
TABLE 57 APAC LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 (%)
TABLE 58 LATIN AMERICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 ($ MILLION)
TABLE 59 LATIN AMERICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 (%)
TABLE 60 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 ($ MILLION)
TABLE 61 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY TECHNIQUE 2021–2027 (%)
TABLE 62 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 63 GLOBAL LIVE-CELL IMAGING MARKET BY APPLICATION2021–2027 (%)
TABLE 64 NORTH AMERICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 65 NORTH AMERICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 (%)
TABLE 66 EUROPE LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 67 EUROPE LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 (%)
TABLE 68 APAC LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 69 APAC LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 (%)
TABLE 70 LATIN AMERICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 71 LATIN AMERICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 (%)
TABLE 72 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 73 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY APPLICATION 2021–2027 (%)
TABLE 74 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 75 GLOBAL LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 76 NORTH AMERICA LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 77 NORTH AMERICA LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 78 EUROPE LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 79 EUROPE LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 80 APAC LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 81 APAC LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 82 LATIN AMERICA LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 83 LATIN AMERICA LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 84 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 85 MIDDLE EAST & AFRICA LIVE-CELL IMAGING MARKET BY END-USER 2021–2027 (%)
TABLE 86 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 87 GLOBAL LIVE-CELL IMAGING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 88 GLOBAL LIVE-CELL IMAGING EQUIPMENT MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 89 GLOBAL LIVE-CELL IMAGING EQUIPMENT MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 90 GLOBAL LIVE-CELL IMAGING CONSUMABLES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 91 GLOBAL LIVE-CELL IMAGING CONSUMABLES MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 92 GLOBAL LIVE-CELL IMAGING SOFTWARE MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 93 GLOBAL LIVE-CELL IMAGING SOFTWARE MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 94 GLOBAL LIVE-CELL IMAGING MARKET BY FLUORESCENCE MICROSCOPY 2021–2027 ($ MILLION)
TABLE 95 GLOBAL LIVE-CELL IMAGING MARKET BY FLUORESCENCE MICROSCOPY 2021–2027 (%)
TABLE 96 GLOBAL LIVE-CELL IMAGING MARKET BY CONFOCAL MICROSCOPY 2021–2027 ($ MILLION)
TABLE 97 GLOBAL LIVE-CELL IMAGING MARKET BY CONFOCAL MICROSCOPY 2021–2027 (%)
TABLE 98 GLOBAL LIVE-CELL IMAGING MARKET BY TRANSMITTED LIGHT MICROSCOPY 2021–2027 ($ MILLION)
TABLE 99 GLOBAL LIVE-CELL IMAGING MARKET BY TRANSMITTED LIGHT MICROSCOPY 2021–2027 (%)
TABLE 100 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021–2027 ($ MILLION)
TABLE 101 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021–2027 (%)
TABLE 102 GLOBAL LIVE-CELL IMAGING MARKET BY CELL BIOLOGY 2021–2027 ($ MILLION)
TABLE 103 GLOBAL LIVE-CELL IMAGING MARKET BY CELL BIOLOGY 2021–2027 (%)
TABLE 104 GLOBAL LIVE-CELL IMAGING MARKET BY DRUG DISCOVERY 2021–2027 ($ MILLION)
TABLE 105 GLOBAL LIVE-CELL IMAGING MARKET BY DRUG DISCOVERY 2021–2027 (%)
TABLE 106 GLOBAL LIVE-CELL IMAGING MARKET BY DEVELOPMENTAL BIOLOGY 2021–2027 ($ MILLION)
TABLE 107 GLOBAL LIVE-CELL IMAGING MARKET BY DEVELOPMENTAL BIOLOGY 2021–2027 (%)
TABLE 108 GLOBAL LIVE-CELL IMAGING MARKET BY STEM CELL RESEARCH 2021–2027 ($ MILLION)
TABLE 109 GLOBAL LIVE-CELL IMAGING MARKET BY STEM CELL RESEARCH 2021–2027 (%)
TABLE 110 GLOBAL LIVE-CELL IMAGING MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 ($ MILLION)
TABLE 111 GLOBAL LIVE-CELL IMAGING MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 (%)
TABLE 112 GLOBAL LIVE-CELL IMAGING MARKET BY ACADEMIC & RESEARCH INSTITUTES 2021–2027 ($ MILLION)
TABLE 113 GLOBAL LIVE-CELL IMAGING MARKET BY ACADEMIC & RESEARCH INSTITUTES 2021–2027 (%)
TABLE 114 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021–2027 ($ MILLION)
TABLE 115 GLOBAL LIVE-CELL IMAGING MARKET BY OTHERS 2021–2027 (%)
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY TECHNIQUE
4.3.3 MARKET SEGMENTATION BY APPLICATION
4.3.4 MARKET SEGMENTATION BY END-USER
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 PREMIUM INSIGHTS
8.1 GLOBAL LIVE-CELL IMAGING MARKET SCENARIO
8.1.1 MARKET SEGMENTATIONS
8.1.2 COMPETITIVE LANDSCAPE
8.1.3 RECENT DEVELOPMENTS IN GLOBAL LIVE-CELL IMAGING MARKET
9 MARKET OPPORTUNITIES & TRENDS
9.1 DEEP LEARNING & ARTIFICIAL INTELLIGENCE ENHANCE LIVE-CELL IMAGING TECHNIQUES
9.2 INCREASED INVESTMENTS IN CELL & GENE THERAPY PRODUCTS
9.3 TRACKING SOLUTIONS FOR LIVE-CELL IMAGING
9.4 ADVANCES IN LIVE-CELL IMAGING
10 MARKET GROWTH ENABLERS
10.1 RISE IN NUMBER OF PATIENTS WITH CANCERS & INFECTIOUS DISEASES
10.2 ADOPTION OF HCS METHODS
10.3 NEW TECHNIQUES IN LIVE-CELL IMAGING
10.4 GROWTH IN R&D ACTIVITIES IN PHARMACEUTICAL INDUSTRY
11 MARKET RESTRAINTS
11.1 HIGH COST OF LIVE-CELL IMAGING SYSTEMS
11.2 CELL VIABILITY & CELLULAR ENVIRONMENT MAINTENANCE CHALLENGES
11.3 PHOTOTOXICITY & PHOTOBLEACHING IN FLUORESCENCE MICROSCOPY
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY PRODUCT
12.2.2 INSIGHTS BY TECHNIQUE
12.2.3 INSIGHTS BY APPLICATION
12.2.4 INSIGHTS BY END-USER
12.2.5 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 EQUIPMENT
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 EQUIPMENT: GEOGRAPHY SEGMENTATION
13.4 CONSUMABLES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 CONSUMABLES: GEOGRAPHY SEGMENTATION
13.5 SOFTWARE
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 SOFTWARE: GEOGRAPHY SEGMENTATION
14 TECHNIQUE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 FLUORESCENCE MICROSCOPY
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 FLUORESCENCE MICROSCOPY: GEOGRAPHY SEGMENTATION
14.4 CONFOCAL MICROSCOPY
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 CONFOCAL MICROSCOPY: GEOGRAPHY SEGMENTATION
14.5 TRANSMITTED LIGHT MICROSCOPY
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 TRANSMITTED LIGHT MICROSCOPY: GEOGRAPHY SEGMENTATION
14.6 OTHERS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 OTHERS: GEOGRAPHY SEGMENTATION
15 APPLICATION
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 CELL BIOLOGY
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 CELL BIOLOGY: GEOGRAPHY SEGMENTATION
15.4 DRUG DISCOVERY
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 DRUG DISCOVERY: GEOGRAPHY SEGMENTATION
15.5 DEVELOPMENTAL BIOLOGY
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 DEVELOPMENTAL BIOLOGY: GEOGRAPHY SEGMENTATION
15.6 STEM CELL RESEARCH
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 STEM CELL RESEARCH: GEOGRAPHY SEGMENTATION
16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 PHARMA & BIOTECH COMPANIES
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION
16.4 ACADEMIC & RESEARCH INSTITUTES
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 ACADEMIC & RESEARCH INSTITUTES: GEOGRAPHY SEGMENTATION
16.5 OTHERS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 OTHERS: GEOGRAPHY SEGMENTATION
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 NORTH AMERICA: PRODUCT
18.2.2 NORTH AMERICA: TECHNIQUE
18.2.3 NORTH AMERICA: APPLICATION
18.2.4 NORTH AMERICA: END-USER
18.3 KEY COUNTRIES
18.3.1 US: MARKET SIZE & FORECAST
18.3.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 EUROPE: PRODUCT
19.2.2 EUROPE: TECHNIQUE
19.2.3 EUROPE: APPLICATION
19.2.4 EUROPE: END-USER
19.3 KEY COUNTRIES
19.3.1 GERMANY: MARKET SIZE & FORECAST
19.3.2 FRANCE: MARKET SIZE & FORECAST
19.3.3 UK: MARKET SIZE & FORECAST
19.3.4 ITALY: MARKET SIZE & FORECAST
19.3.5 SPAIN: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 APAC: PRODUCT
20.2.2 APAC: TECHNIQUE
20.2.3 APAC: APPLICATION
20.2.4 APAC: END-USER
20.3 KEY COUNTRIES
20.3.1 CHINA: MARKET SIZE & FORECAST
20.3.2 JAPAN: MARKET SIZE & FORECAST
20.3.3 INDIA: MARKET SIZE & FORECAST
20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.3.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 LATIN AMERICA: PRODUCT
21.2.2 LATIN AMERICA: TECHNIQUE
21.2.3 LATIN AMERICA: APPLICATION
21.2.4 LATIN AMERICA: END-USER
21.3 KEY COUNTRIES
21.3.1 BRAZIL: MARKET SIZE & FORECAST
21.3.2 MEXICO: MARKET SIZE & FORECAST
21.3.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 MIDDLE EAST & AFRICA: PRODUCT
22.2.2 MIDDLE EAST & AFRICA: TECHNIQUE
22.2.3 MIDDLE EAST & AFRICA: APPLICATION
22.2.4 MIDDLE EAST & AFRICA: END-USER
22.3 KEY COUNTRIES
22.3.1 TURKEY: MARKET SIZE & FORECAST
22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22.3.4 UAE: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
23.2.1 DANAHER
23.2.2 AGILENT TECHNOLOGIES
23.2.3 PERKINELMER
23.2.4 MERCK KGAA
23.2.5 ZEISS
23.2.6 THERMO FISHER SCIENTIFIC
24 KEY COMPANY PROFILES
24.1 DANAHER
24.1.1 BUSINESS OVERVIEW
24.1.2 DANAHER IN GLOBAL LIVE-CELL IMAGING MARKET
24.1.3 PRODUCT OFFERINGS
24.1.4 KEY STRATEGIES
24.1.5 KEY STRENGTHS
24.1.6 KEY OPPORTUNITIES
24.2 AGILENT TECHNOLOGIES
24.2.1 BUSINESS OVERVIEW
24.2.2 AGILENT TECHNOLOGIES IN GLOBAL LIVE-CELL IMAGING MARKET
24.2.3 PRODUCT OFFERINGS
24.2.4 KEY STRATEGIES
24.2.5 KEY STRENGTHS
24.2.6 KEY OPPORTUNITIES
24.3 PERKINELMER
24.3.1 BUSINESS OVERVIEW
24.3.2 PERKINELMER IN GLOBAL LIVE-CELL IMAGING MARKET
24.3.3 PRODUCT OFFERINGS
24.3.4 KEY STRATEGIES
24.3.5 KEY STRENGTHS
24.3.6 KEY OPPORTUNITIES
24.4 MERCK KGAA
24.4.1 BUSINESS OVERVIEW
24.4.2 MERCK KGAA IN GLOBAL LIVE-CELL IMAGING MARKET
24.4.3 PRODUCT OFFERINGS
24.4.4 KEY STRATEGIES
24.4.5 KEY STRENGTHS
24.4.6 KEY OPPORTUNITIES
24.5 ZEISS
24.5.1 BUSINESS OVERVIEW
24.5.2 ZEISS IN GLOBAL LIVE-CELL IMAGING MARKET
24.5.3 PRODUCT OFFERINGS
24.5.4 KEY STRATEGIES
24.5.5 KEY STRENGTHS
24.5.6 KEY OPPORTUNITIES
24.6 THERMO FISHER SCIENTIFIC
24.6.1 BUSINESS OVERVIEW
24.6.2 THERMO FISHER SCIENTIFIC IN GLOBAL LIVE-CELL IMAGING MARKET
24.6.3 PRODUCT OFFERINGS
24.6.4 KEY STRATEGIES
24.6.5 KEY STRENGTHS
24.6.6 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 AXION BIOSYSTEMS
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 BD
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 BIO-RAD LABORATORIES
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 BLUE-RAY BIOTECH
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 BRUKER
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 EPPENDORF
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 ETALUMA
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 GRACE BIO-LABS
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 IBIDI GMBH
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 INTELLIGENT IMAGING INNOVATIONS
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 KEYENCE CORPORATION
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 LOGOS BIOSYSTEMS
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 NANOENTEK
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 NANOLIVE SA
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 NIKON
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 EVIDENT
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 ONI
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 OXFORD INSTRUMENTS
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 PHASE FOCUS
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 PHASE HOLOGRAPHIC IMAGING PHI AB
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 PROTEINTECH GROUP
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 SARTORIUS AG
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
25.23 SONY BIOTECHNOLOGY
25.23.1 BUSINESS OVERVIEW
25.23.2 PRODUCT OFFERINGS
25.24 TOMOCUBE
25.24.1 BUSINESS OVERVIEW
25.24.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY PRODUCT
27.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
27.1.2 EUROPE: PRODUCT SEGMENTATION
27.1.3 APAC: PRODUCT SEGMENTATION
27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
27.2 MARKET BY TECHNIQUE
27.2.1 NORTH AMERICA: TECHNIQUE SEGMENTATION
27.2.2 EUROPE: TECHNIQUE SEGMENTATION
27.2.3 APAC: TECHNIQUE SEGMENTATION
27.2.4 LATIN AMERICA: TECHNIQUE SEGMENTATION
27.2.5 MIDDLE EAST & AFRICA: TECHNIQUE SEGMENTATION
27.3 MARKET BY APPLICATION
27.3.1 NORTH AMERICA: APPLICATION SEGMENTATION
27.3.2 EUROPE: APPLICATION SEGMENTATION
27.3.3 APAC: APPLICATION SEGMENTATION
27.3.4 LATIN AMERICA: APPLICATION SEGMENTATION
27.3.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
27.4 MARKET BY END-USER
27.4.1 NORTH AMERICA: END-USER SEGMENTATION
27.4.2 EUROPE: END-USER SEGMENTATION
27.4.3 APAC: END-USER SEGMENTATION
27.4.4 LATIN AMERICA: END-USER SEGMENTATION
27.4.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
27.5 MARKET BY GEOGRAPHY
27.5.1 EQUIPMENT: GEOGRAPHY SEGMENTATION
27.5.2 CONSUMABLES: GEOGRAPHY SEGMENTATION
27.5.3 SOFTWARE: GEOGRAPHY SEGMENTATION
27.5.4 FLUORESCENCE MICROSCOPY: GEOGRAPHY SEGMENTATION
27.5.5 CONFOCAL MICROSCOPY: GEOGRAPHY SEGMENTATION
27.5.6 TRANSMITTED LIGHT MICROSCOPY: GEOGRAPHY SEGMENTATION
27.5.7 OTHERS: GEOGRAPHY SEGMENTATION
27.5.8 CELL BIOLOGY: GEOGRAPHY SEGMENTATION
27.5.9 DRUG DISCOVERY: GEOGRAPHY SEGMENTATION
27.5.10 DEVELOPMENTAL BIOLOGY: GEOGRAPHY SEGMENTATION
27.5.11 STEM CELL RESEARCH: GEOGRAPHY SEGMENTATION
27.5.12 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION
27.5.13 ACADEMIC & RESEARCH INSTITUTES: GEOGRAPHY SEGMENTATION
27.5.14 OTHERS: GEOGRAPHY SEGMENTATION
28 APPENDIX
28.1 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the expected live cell imaging market size by 2027?
What is the live cell imaging market growth?
What are the latest trends in the live cell imaging market?
Who are the market leaders in the global live cell imaging market?
Which region has the largest live cell imaging market share?
Other RELATED Reports
Cell and Gene Therapy Market - Global Outlook & Forecast 2022-2027
Published : January 2022
Mobile Medical Imaging Services Market - Global Outlook & Forecast 2022-2027
Published : July 2022
